DOI QR코드

DOI QR Code

Exploring the underlying factors of COVID-19 vaccination hesitancy in Ahvaz, Iran: a comprehensive cross-sectional study

  • Poorandokht Afshari (Midwifery Department, Reproductive Health Promotion Research Center, Ahvaz Jundishapur University of Medical Sciences) ;
  • Seyed Mohammad Alavi (Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences) ;
  • Parvin Abedi (Midwifery Department, Menopause Andropause Research Center, Ahvaz Jundishapur University of Medical Sciences) ;
  • Maryam Beheshtinasab (Midwifery Department, Reproductive Health Promotion Research Center, Ahvaz Jundishapur University of Medical Sciences) ;
  • Shohreh Dashtpayma (Midwifery Department, Reproductive Health Promotion Research Center, Ahvaz Jundishapur University of Medical Sciences) ;
  • Homayon Amiri (Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences)
  • Received : 2022.12.03
  • Accepted : 2023.02.03
  • Published : 2023.04.30

Abstract

Purpose: Around 70% of the Iranian population had received two doses of coronavirus disease 2019 (COVID-19) vaccines by the end of 2021. In this study, we evaluated the reasons for vaccination refusal among people in Ahvaz, Iran. Materials and Methods: In this cross-sectional study, 800 participants (400 vaccinated and 400 unvaccinated) were recruited. A demographic questionnaire was completed through interviews. The unvaccinated participants were asked about the reasons for their refusal. The Shapiro-Wilk test, independent t-test, chi-square test, and logistic regression were used for analyzing data. Results: Older people were 1.018 times more likely to refrain from vaccination (95% confidence interval [CI], 1.001-1.039; p=043). People who were manual workers as well as those who were unemployed/housewives were 0.288 and 0.423 times less likely to receive vaccination, respectively. Those with high school education and married women were 0.319 and 0.280 times less likely to receive vaccination, respectively (95% CI, 198-0.515; p<0.001; 95% CI, 0.186-0.422; p<0.001). Participants who had hypertension or suffered from neurological disorders were more likely to receive the vaccination. Finally, people affected with severe COVID-19 infection were 3.157 times more likely to get vaccinated (95% CI, 1.672-5.961; p<0.001). Conclusion: The results of this study showed that lower level of education and older age were contributed to reluctance for vaccination, while having chronic diseases or being already infected with severe COVID-19 infection were associated with more acceptance of vaccination.

Keywords

Acknowledgement

This study was extracted from a research project that was financially supported by Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. We would like to thank all participants who participated in this study.

References

  1. CSSEGISandData: COVID-19 data repository by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University [Internet]. San Francisco (CA): GitHub Inc.; 2022 [cited 2023 Mar 17]. Available from: https://github.com/CSSEGISandData/COVID-19 
  2. REUTERS. COVID-19 Tracker: Asia and the Middle East: Iran [Internet]. London: REUTERS; 2022 [cited 2023 Mar 15]. Available from: https://graphics.reuters.com/worldcoronavirus-tracker-and-maps/countries-and-territories/iran/ 
  3. World Health Organization. Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed: interim guidance, 12 July 2021. Geneva: World Health Organization; 2021. 
  4. Suthar AB, Wang J, Seffren V, Wiegand RE, Griffing S, Zell E. Public health impact of COVID-19 vaccines in the US: observational study. BMJ 2022;377:e069317. 
  5. World Health Organization. Vaccines and immunization: overview [Internet]. Geneva: World Health Organization; 2020 [cited 2023 Mar 1]. Available from: https://www.who.int/health-topics/vaccines-and-immunization#tab=tab_1 
  6. Steinert JI, Sternberg H, Prince H, et al. COVID-19 vaccine hesitancy in eight European countries: prevalence, determinants, and heterogeneity. Sci Adv 2022;8:eabm9825. 
  7. Khubchandani J, Bustos E, Chowdhury S, Biswas N, Keller T. COVID-19 vaccine refusal among nurses worldwide: review of trends and predictors. Vaccines (Basel) 2022;10:230. 
  8. Yigit M, Ozkaya-Parlakay A, Senel E. Evaluation of COVID-19 vaccine refusal in parents. Pediatr Infect Dis J 2021;40:e134-6. 
  9. Nakhostin-Ansari A, Zimet GD, Khonji MS, et al. Acceptance or rejection of the COVID-19 vaccine: a study on Iranian people's opinions toward the COVID-19 vaccine. Vaccines (Basel) 2022;10:670. 
  10. Abbasi N, Ghadiri F, Moghadasi AN, et al. COVID-19 vaccine hesitancy in Iranian patients with multiple sclerosis. Mult Scler Relat Disord 2022;60:103723. 
  11. Micaeili-Mirak S, Namazi S, Ghadrdan E. A survey of Iranian population attitude about vaccination against COVID-19 and evaluation of its spontaneous reporting of adverse effects. J Biomed Sci 2021;3:1234-40. 
  12. VaccinesWork. There are four types of COVID-19 vaccines: here's how they work [Internet]. Geneva: GAVI; 2020 [cited 2023 Mar 1]. Available from: https://www.gavi.org/vaccineswork/there-are-four-types-covid-19-vaccines-heres-how-they-work 
  13. Moini A, Rabiei M, Pirjani R, Abiri A, Maleki-Hajiagha A. COVID-19 vaccine hesitancy among pregnant women and their reported reasons for vaccine refusal: a prospective study in Tehran, Iran. Vaccine 2023;41:1490-5. 
  14. Samo AA, Sayed RB, Valecha J, Baig NM, Laghari ZA. Demographic factors associated with acceptance, hesitancy, and refusal of COVID-19 vaccine among residents of Sukkur during lockdown: a cross sectional study from Pakistan. Hum Vaccin Immunother 2022;18:2026137. 
  15. Maleva TM, Kartseva MA, Korzhuk SV. Socio-demographic determinants of COVID-19 vaccine uptake in Russia in the context of mandatory vaccination of employees. Popul Econ 2021;5:30-49. 
  16. Andrade G. Predictive demographic factors of COVID-19 vaccine hesitancy in Venezuela: a cross-sectional study. Vacunas 2022;23:S22-5. 
  17. Jiang N, Gu P, Sun X, et al. Acceptance of COVID-19 vaccines in patients with chronic diseases: a cross-sectional study. J Clin Nurs 2022;31:3286-300. 
  18. Tenforde MW, Self WH, Adams K, et al. Association between mRNA vaccination and COVID-19 hospitalization and disease severity. JAMA 2021;326:2043-54. 
  19. Sun Y, Li B, Li N, et al. Acceptance of COVID-19 vaccine among high-risk occupations in a Port city of China and multifaceted strategies for increasing vaccination coverage: a cross-sectional study. Risk Manag Healthc Policy 2022;15:643-55. 
  20. Nojomi M, Moradi-Lakeh M, Pourmalek F. COVID-19 in Iran: what was done and what should be done. Med J Islam Repub Iran 2021;35:97. 
  21. Fotoukian Z, Navabi N, Chaboksavar F, Mohammadkhah F. Strategies to increase the acceptance of COVID-19 vaccine in the Iranian community. J Isfahan Med Sch 2021;39:341-3.